Giulia Maddalena

6PUBLICATIONS
70CO-AUTHORS
Molecular targetsCancer geneticsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2026
Overall survival of immunotherapy versus standard of care in chemorefractory microsatellite stable metastatic colorectal cancer: a propensity score matched analysis of 708 patients.

|Aug 12, 2026
Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer Center.

|Nov 18, 2025
Prognosis and treatment response stratification according to loss of proofreading (LOP) POLE variants.

Giulia Maddalena, Fadl A Zeineddine, Saikat Chowdhury

|Apr 28, 2025
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.

Michelangelo Marasco, Dinesh Kumar, Santiago Garcia Borrego

|Aug 23, 2023
Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study.

Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger

|Jul 13, 2023
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors.

Claire Gallois, Matteo Landi, Julien Taieb

Pageof 1

Frequent Collaborators

4 joint publications

Sara Lonardi

3 joint publications

Francesca Bergamo

2 joint publications

Federico Nichetti

2 joint publications

John Paul Shen